Physician
Tots & Teens Pediatrics, LLC
Tots & Teens Pediatrics, LLC was paid $5.41M by Medicaid between Jan 2019 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoTOTS & TEENS PEDIATRICS, LLC
SAINT CLOUD, FL 34769
SAINT CLOUD, FL 34769
33aNPI1427432590assigned 07/17/2015
33bProvider typePediatrics Physician
28Total paid$5.41M
24GClaims121,102
24DCodes billed59
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#62 of 971
Median peer was paid$238K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 17,250 | $701K | |
| 2020 | 19,812 | $823K | |
| 2021 | 21,933 | $986K | |
| 2022 | 23,597 | $1.12M | |
| 2023 | 24,438 | $1.16M | |
| 2024incomplete | 14,072 | $623K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 23,932 | 20,921 | $1.70M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 7,894 | 7,288 | $841K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 5,852 | 5,687 | $737K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 10.0% | 4,705 | 4,507 | $538K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.4% | 3,998 | 3,872 | $455K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.3% | 2,314 | 2,267 | $287K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.4% | 12,353 | 11,749 | $239K |
| 90461 | 1.7% | 6,943 | 6,648 | $92K | |
| 99383 | 1.4% | 569 | 549 | $77K | |
| 92552 | 1.4% | 7,337 | 7,080 | $76K | |
| 99381 | 1.3% | 764 | 677 | $69K | |
| 99384 | <1% | 260 | 259 | $40K |
47 more codes
| 90671 | <1% | 726 | $37K | |
| 99382 | <1% | 260 | $36K | |
| 87428 | <1% | 810 | $28K | |
| 90670 | <1% | 2,678 | $26K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,064 | $25K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 222 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,965 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 344 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,663 | $9K |
| 90651 | <1% | 1,010 | $8K | |
| 90681 | <1% | 1,336 | $7K | |
| 90716 | <1% | 1,896 | $4K | |
| 90698 | <1% | 2,507 | $3K | |
| 0071A | <1% | 79 | $2K | |
| 90633 | <1% | 2,241 | $2K | |
| 90661 | <1% | 73 | $2K | |
| 83655 | <1% | 560 | $2K | |
| 99173 | <1% | 8,507 | $2K | |
| 90619 | <1% | 164 | $2K | |
| 0072A | <1% | 56 | $2K | |
| 90620 | <1% | 212 | $2K | |
| 90707 | <1% | 1,900 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 174 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 600 | $1K |
| 90686 | <1% | 1,629 | $1K | |
| 36416 | <1% | 606 | $932.12 | |
| 90734 | <1% | 521 | $842.42 | |
| 90744 | <1% | 1,396 | $715.12 | |
| 0001A | <1% | 25 | $701.27 | |
| 85018 | <1% | 791 | $641.07 | |
| 90700 | <1% | 459 | $476.56 | |
| 0002A | <1% | 19 | $464.84 | |
| 90674 | <1% | 105 | $439.02 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 510 | $301.90 |
| 90696 | <1% | 378 | $282.36 | |
| 96127 | <1% | 297 | $180.09 | |
| 87631 | <1% | 123 | $125.99 | |
| 90715 | <1% | 411 | $96.02 | |
| 90647 | <1% | 494 | $70.17 | |
| 99072 | <1% | 158 | $48.01 | |
| 90688 | <1% | 44 | $40.83 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 28 | $28.00 |
| 90713 | <1% | 195 | $24.01 | |
| 81003 | <1% | 97 | $17.24 | |
| 90648 | <1% | 170 | $11.56 | |
| 90723 | 0% | 551 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 127 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELBANNA, ALAA (MANAGER)